Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.40 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.40 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25269989 | 0.96 | KDM4E (0.47) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL6231966 | 0.93 | KDM4E (0.47) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL22472167 | 0.89 | KDM4E (0.44) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL27983000 | 0.89 | KDM4E (0.44) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL27888801 | 0.88 | KDM4E (0.55) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL246239 | 0.84 | THRB (0.55) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL23878372 | 0.83 | HTT (0.42) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL23878370 | 0.82 | HTT (0.49) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL23878371 | 0.82 | HTT (0.43) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL710800 | 0.81 | HTT (0.41) | KDM4EALDH1A1MEN1KMT2AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9782329-B2 | Hardenable dental composition containing a mixture of agglomerated and aggregated nano-particles, kit of parts and use thereof | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-10-10 | — | — | US | claimed |
| EP-3019141-A1 | HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF | 3M Innovative Properties Company (US) | 2016-05-18 | — | — | EP | claimed |
| WO-2015006087-A1 | HARDENABLE DENTAL COMPOSITION CONTAINING A MIXTURE OF AGGLOMERATED AND AGGREGATED NANO-PARTICLES, KIT OF PARTS AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-01-15 | — | — | WO | claimed |
| WO-2006059984-A1 | MODIFIED POROUS MATERIALS AND METHOD OF FORMING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060115644-A1 | Modified porous materials and method of forming the same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-06-01 | — | — | US | claimed |
| US-6979702-B1 | Ionomer composite compositions | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2005-12-27 | — | — | US | claimed |
| WO-2000055253-A1 | IONOMER COMPOSITE COMPOSITIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2000-09-21 | — | — | WO | claimed |
| US-5321053-A | Curable mixture of vinyl monomer containing acidic group and photoinitiator | KURARAY CO., LTD. (JP) | 1994-06-14 | — | — | US | claimed |
| US-20260086088-A1 | BIOINKS, METHODS OF PRINTING AND RELATED USES | UNIV MCMASTER (CA) | 2026-03-26 | — | — | US | disclosed |
| EP-4100236-B1 | A PROCESS FOR PRODUCING A SURFACE-MODIFIED 3-DIMENSIONAL ARTICLE BY ADDITIVE-MANUFACTURING AND 3-DIMENSIONAL ARTICLE WITH A MODIFIED SURFACE | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024110805-A1 | CURABLE COMPOSITION FOR USE IN A PROCESS OF TREATING A DENTAL SITUATION IN THE MOUTH OF A PATIENT | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-05-30 | — | — | WO | disclosed |
| CN-112997301-B | Composition for low dielectric heat conduction material and low dielectric heat conduction material | 北川工业株式会社 | 2024-03-01 | — | — | CN | disclosed |
| WO-2024018305-A1 | CURABLE COMPOSITION FOR PRODUCING TRANSPARENT ORTHODONTIC ATTACHMENTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-3749276-B1 | MICROCAPSULE WITH A POROUS OR HOLLOW CORE AND PH-SENSITIVE SHELL AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-01-03 | — | — | EP | disclosed |
| EP-0717977-A2 | Fluoride releasing dental composite material | THERA Patent GmbH & Co. KG Gesellschaft für industrielle Schutzrechte (DE) | 1996-06-26 | — | — | EP | disclosed |
| EP-0694298-A1 | PREFORMED GLASS IONOMER FILLER WHICH CAN SUSTAINEDLY RELEASE FLUORIDE ION AND DENTAL COMPOSITION CONTAINING THE SAME | SHOFU INC. (JP) | 1996-01-31 | — | — | EP | disclosed |
| US-RE35135-E | Dental material; mixture of radical-polymerizable monomer, alpha-ketocarbonyl and aromatic amine | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1995-12-26 | — | — | US | disclosed |
| EP-0136186-B1 | PHOTOCURABLE RESIN COMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1989-09-06 | — | — | EP | disclosed |
| US-4548689-A | RADICAL POLYMERIZABLE MONOMER, KETOCARBONYL COMPOUND AND MERCAPTOB | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-10-22 | — | — | US | disclosed |
| EP-0136186-A2 | Photocurable resin composition | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-04-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260086088-A1 | BIOINKS, METHODS OF PRINTING AND RELATED USES | COL2A1, S100P, ILK | KDM4E 2829/4885ALDH1A1 771/4885MEN1 3856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.